Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49971,301,0.95 [0.75-1.19],0.6377030908088527
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51774,401,1.14 [0.93-1.39],0.2019870488198169
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",51241,2793,1.02 [0.95-1.10],0.544202179761538
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51813,865,1.06 [0.92-1.21],0.4223466560304815
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,50246,7079,1.01 [0.96-1.06],0.6194077446239964
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50440,6463,1.10 [1.05-1.16],0.0002156777459873
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51300,2461,1.01 [0.93-1.10],0.7379326751122972
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51627,175,1.12 [0.83-1.51],0.4679050984462283
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47666,1960,1.03 [0.94-1.13],0.4975465704619212
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,46049,2224,1.14 [1.05-1.24],0.0021347898932698
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45797,522,1.03 [0.86-1.22],0.775422656124261
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36386,4002,1.08 [1.01-1.15],0.0257914886691357
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45487,790,1.15 [0.99-1.32],0.0631253809597887
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51741,2902,1.04 [0.96-1.12],0.3602868741371549
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,51970,1022,1.06 [0.94-1.20],0.3355552675515649
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50321,1873,1.03 [0.94-1.13],0.4907670214562287
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51833,2163,1.01 [0.93-1.10],0.7531658835307904
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,49242,403,1.14 [0.93-1.39],0.2005949073012071
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,52073,100,1.04 [0.70-1.55],0.8431863036733973
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51560,1890,1.01 [0.92-1.11],0.7872958067817818
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51608,156,1.04 [0.75-1.43],0.8327530216608097
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51911,319,1.01 [0.80-1.27],0.9422405878149966
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51873,281,0.98 [0.77-1.25],0.8570718459006965
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49296,848,1.11 [0.97-1.28],0.1190806297443158
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,49011,563,0.91 [0.77-1.08],0.2831742631899171
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,49061,222,1.16 [0.88-1.51],0.2869251557509478
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,52031,108,1.68 [1.16-2.42],0.0057354595507429
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51942,306,1.18 [0.94-1.49],0.1547720517429165
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,51736,100,1.25 [0.84-1.88],0.2709980469097624
PLA2G1B,Phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51766,130,1.13 [0.79-1.61],0.4950058848819479
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,51479,595,0.95 [0.80-1.12],0.5478576583951462
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51897,118,0.85 [0.58-1.24],0.3991404397738917
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51857,126,0.77 [0.54-1.11],0.1615662521222079
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23945,131,1.04 [0.73-1.47],0.8422533524662179
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51403,2912,0.98 [0.91-1.06],0.641521829821847
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,52045,116,1.00 [0.68-1.46],0.9961860373622294
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51941,133,1.18 [0.83-1.67],0.3546878804988057
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,52022,219,1.04 [0.79-1.36],0.7728476726721493
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,27994,182,0.98 [0.72-1.34],0.906057318297145
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,52027,733,1.01 [0.87-1.17],0.8623757761813513
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,52027,603,0.99 [0.84-1.17],0.9317290094789192
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51855,148,0.71 [0.52-0.98],0.0356797116059771
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,52021,439,0.94 [0.78-1.13],0.5066740284362576
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,51942,710,0.97 [0.84-1.13],0.7330743660187157
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51839,1245,1.03 [0.92-1.16],0.5696511619753304
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,52007,870,0.99 [0.86-1.13],0.8459939420892195
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,22748,137,0.98 [0.68-1.41],0.9245181065697122
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22841,169,1.00 [0.72-1.38],0.997303005999176
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41456,104,0.80 [0.54-1.18],0.2685154102002308
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41491,139,1.14 [0.81-1.61],0.4478950298939733
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51972,242,1.08 [0.83-1.41],0.5443369959019739
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",51973,237,1.09 [0.83-1.42],0.5477497656234003
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,27072,602,0.89 [0.75-1.06],0.1838771118963042
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,36107,669,0.92 [0.79-1.08],0.3148961160266668
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,41454,102,0.92 [0.62-1.37],0.6718233103430787
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41732,380,1.37 [1.11-1.69],0.0031560014585249
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41765,413,1.08 [0.89-1.31],0.4319952630867268
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22976,190,0.95 [0.71-1.28],0.7326087831356554
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41517,165,0.82 [0.61-1.12],0.211525461937033
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41570,218,1.16 [0.89-1.52],0.2794773947151723
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41549,197,1.03 [0.78-1.37],0.812596158883756
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22929,143,1.00 [0.71-1.42],0.9827679484938232
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41541,189,0.80 [0.60-1.06],0.1193355512717217
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19976,1410,1.03 [0.92-1.14],0.6305850192469198
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41583,231,1.09 [0.84-1.43],0.5166291308807558
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41501,149,0.77 [0.56-1.06],0.109840388247436
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41560,208,1.06 [0.80-1.41],0.6757740613385508
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,51673,405,1.00 [0.81-1.23],0.9707175964293978
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,51992,178,1.26 [0.92-1.72],0.1448461406027351
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Melanoma in situ,41421,163,0.80 [0.58-1.10],0.1670243040555729
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41536,184,1.13 [0.84-1.52],0.4146172865122918
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41679,327,1.21 [0.97-1.51],0.0953860494061999
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41808,456,0.88 [0.74-1.06],0.1830930784951013
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41553,201,1.04 [0.78-1.39],0.7830326303100967
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,51708,311,0.86 [0.68-1.08],0.2035083324814983
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43528,2176,0.95 [0.87-1.04],0.2598372732605298
PLA2G1B,Phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43645,2293,0.97 [0.90-1.06],0.5599415322198129
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51480,693,0.88 [0.76-1.03],0.105939600923879
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48253,224,2.74 [2.19-3.42],8.32921482568251e-19
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50930,143,1.17 [0.84-1.64],0.3605967779553892
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50466,5848,1.06 [1.00-1.12],0.0325598782286175
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,49099,99,1.07 [0.72-1.59],0.7408982912128206
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,51228,101,1.21 [0.82-1.80],0.3351065126197213
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,51089,3060,1.10 [1.03-1.19],0.0078035512256608
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,51087,3058,1.10 [1.03-1.19],0.007774919343579
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,48205,176,1.54 [1.14-2.07],0.0047635580591824
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51411,2411,1.10 [1.02-1.20],0.0175415390322504
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51356,229,1.03 [0.79-1.35],0.8293008686775923
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50918,131,0.81 [0.57-1.14],0.2185258942120814
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50907,120,0.86 [0.60-1.24],0.4248643019783003
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51685,558,0.98 [0.83-1.16],0.8391365132784194
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51857,113,1.34 [0.92-1.96],0.1301371973504382
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51587,460,0.95 [0.79-1.14],0.591139661076019
PLA2G1B,Phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,49214,214,0.71 [0.54-0.93],0.0129217500291202
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40284,643,1.09 [0.93-1.28],0.2855910707771053
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48560,233,0.58 [0.46-0.74],7.339771993204855e-06
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48584,257,0.49 [0.39-0.60],7.87649865423091e-12
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39752,111,1.12 [0.76-1.65],0.5716333050098765
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48352,138,1.36 [0.97-1.91],0.0751201361604027
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,47202,479,0.93 [0.78-1.12],0.4439933065851779
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",51111,1140,0.92 [0.82-1.03],0.165585124465088
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50510,539,1.07 [0.90-1.28],0.4132330983429183
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,50231,260,0.98 [0.77-1.25],0.8607205291278464
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51359,3145,0.99 [0.92-1.07],0.7905988504450138
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45367,3051,0.95 [0.88-1.02],0.1785370199902196
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39775,134,1.00 [0.71-1.42],0.982717067254984
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",48002,157,0.92 [0.66-1.27],0.5939326260539939
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,40207,566,1.33 [1.12-1.57],0.0010757483356933
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39765,124,0.71 [0.49-1.02],0.0604240077295861
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46767,7126,1.02 [0.98-1.08],0.3138251111777785
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,40033,392,0.85 [0.69-1.04],0.1124020751172022
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40762,1121,1.01 [0.90-1.14],0.8570837133051302
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51909,660,1.35 [1.16-1.58],0.0001504340906642
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51528,279,2.17 [1.75-2.70],2.767146210742553e-12
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39896,255,0.89 [0.69-1.15],0.3756655258574463
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39763,122,1.32 [0.91-1.91],0.1376034346187876
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50982,3137,1.02 [0.95-1.10],0.585477893397989
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,40167,526,1.42 [1.20-1.68],5.605138501518979e-05
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40247,606,1.46 [1.25-1.71],2.6887465380943622e-06
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40922,1281,1.11 [0.99-1.24],0.0712142267784241
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39882,241,1.11 [0.86-1.43],0.4392200027923871
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51511,262,2.19 [1.75-2.74],7.149520369753276e-12
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40853,1212,1.04 [0.93-1.17],0.508790434878315
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40607,966,0.80 [0.70-0.91],0.0005282003732191
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46863,140,1.44 [1.03-2.02],0.0354102348242205
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49686,10045,1.02 [0.98-1.06],0.3181704661820814
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47945,100,1.06 [0.70-1.60],0.7746358736311356
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47958,113,0.97 [0.66-1.44],0.8808071723018033
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51692,3934,0.96 [0.90-1.02],0.1547416339092301
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51694,3929,0.96 [0.90-1.02],0.1546628187437961
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47950,105,0.93 [0.63-1.38],0.725685082442944
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51375,2436,0.94 [0.87-1.02],0.1674705546251841
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42833,3192,1.07 [1.00-1.15],0.0648791650745681
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,52047,460,0.70 [0.59-0.83],6.124742114315447e-05
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,50139,168,1.04 [0.77-1.41],0.7781608589740097
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,49146,207,0.88 [0.66-1.16],0.3665551455444168
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,49226,287,0.89 [0.70-1.13],0.3368253019634406
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39975,334,1.16 [0.92-1.46],0.2076190382527236
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47371,310,0.33 [0.27-0.40],4.2953396766818585e-31
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4278,174,0.98 [0.76-1.27],0.8742289995406747
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4559,512,1.00 [0.86-1.16],0.9874191389147698
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,47189,128,0.67 [0.47-0.95],0.0233634964298027
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4216,115,1.70 [1.25-2.30],0.0006639853468618
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50775,3714,0.65 [0.61-0.69],2.5234638092325488e-39
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50681,710,0.90 [0.78-1.05],0.1801225263365782
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47461,738,0.95 [0.82-1.10],0.4621305866054375
PLA2G1B,Phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,41198,1557,1.04 [0.94-1.15],0.4232932211672687
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51845,488,0.94 [0.78-1.12],0.4721268115007765
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49796,330,1.46 [1.18-1.80],0.0004422210526393
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,47556,2411,1.03 [0.95-1.11],0.5328353941490511
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49947,481,1.41 [1.18-1.69],0.0001327135941958
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49586,120,0.97 [0.68-1.39],0.8800564705563596
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49871,405,1.32 [1.08-1.60],0.0054782994540939
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32285,3859,1.07 [1.00-1.14],0.0466204733154278
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,43863,875,1.04 [0.91-1.19],0.576005801363233
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51956,856,1.06 [0.93-1.22],0.3954746658208042
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28814,388,1.35 [1.09-1.66],0.0051201407154479
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43329,341,1.15 [0.92-1.43],0.2221589841476238
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",43181,193,1.33 [0.99-1.78],0.0557789632232061
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,52070,103,0.98 [0.67-1.43],0.9130376994270272
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,45116,2128,1.05 [0.96-1.15],0.2596878290528409
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49295,4186,1.09 [1.02-1.16],0.007989829505988
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45421,15258,0.92 [0.89-0.95],5.326191597334939e-07
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49278,527,0.98 [0.82-1.16],0.8040514388534902
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,43137,149,1.00 [0.72-1.39],0.9832944681053
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51656,2224,1.11 [1.02-1.20],0.0179283758206885
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,47278,13114,0.92 [0.89-0.96],2.3675917869473284e-05
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47314,13150,0.93 [0.90-0.97],0.0001551969067154
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51728,160,0.61 [0.46-0.82],0.0010472147483986
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34519,355,1.33 [1.08-1.65],0.0079091156110856
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34444,280,3.99 [3.45-4.63],1.0934255037330294e-75
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,51781,2377,1.09 [1.00-1.18],0.0387530357821676
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,50214,215,0.87 [0.66-1.14],0.3210069032949748
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49641,4496,1.04 [0.98-1.10],0.1939264231639605
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51312,1125,0.86 [0.76-0.97],0.0119809613018006
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43721,733,1.20 [1.03-1.39],0.0170794917640895
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,51102,1689,1.00 [0.91-1.10],0.9583327966800408
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46572,1427,1.06 [0.95-1.18],0.2726046748232294
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51884,313,1.22 [0.98-1.53],0.0789525669145281
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",52013,621,0.96 [0.81-1.12],0.5777103485304385
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48861,110,0.70 [0.49-1.02],0.060254187823008
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,49625,159,1.19 [0.87-1.64],0.2757049579237515
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43841,853,1.07 [0.93-1.23],0.3201288024497379
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49670,204,1.14 [0.87-1.50],0.3524758245358481
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49949,483,0.95 [0.79-1.14],0.5744334533186803
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43348,360,1.20 [0.97-1.49],0.096669470352799
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48948,197,0.91 [0.68-1.20],0.4934608847816867
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48849,98,0.70 [0.47-1.04],0.0815277700688987
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,49180,130,1.11 [0.78-1.57],0.554671287309776
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,49029,278,1.10 [0.87-1.39],0.4204645382551334
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,45075,2087,1.15 [1.06-1.26],0.0015050987797829
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49516,112,0.59 [0.41-0.83],0.0028838569059701
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50561,1095,1.13 [1.00-1.27],0.0552681150893525
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50835,696,1.26 [1.09-1.46],0.0016934951463121
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50285,1235,0.87 [0.78-0.97],0.0143609232390478
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,29102,676,1.13 [0.97-1.33],0.1253219639895768
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,50220,816,1.06 [0.92-1.21],0.4093108965166445
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49442,691,0.93 [0.80-1.08],0.3452021134447182
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,51091,952,1.12 [0.99-1.28],0.0814739572849412
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51932,1323,1.01 [0.90-1.12],0.9214092992228397
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43693,705,1.09 [0.93-1.27],0.2794895303210245
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50824,685,1.25 [1.08-1.45],0.0027121713704836
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49439,389,0.90 [0.74-1.10],0.3240144956048512
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51289,1290,0.87 [0.78-0.97],0.0149899224573003
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",51247,1368,0.88 [0.79-0.98],0.0215850901699069
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,50157,120,0.99 [0.68-1.43],0.9469395193987508
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49626,161,1.78 [1.31-2.41],0.000218303824967
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50663,476,1.09 [0.90-1.31],0.3714022947508333
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49937,524,0.94 [0.79-1.12],0.4912182213415915
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,49606,855,0.97 [0.85-1.11],0.6739687786317843
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49494,172,0.90 [0.66-1.22],0.5068445494692098
PLA2G1B,Phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51612,1506,1.04 [0.93-1.15],0.5099987850197201
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51827,720,0.55 [0.48-0.63],7.027405393331273e-18
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45553,2880,0.92 [0.85-1.00],0.0388380871376117
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,50754,8081,0.93 [0.89-0.97],0.001698541614789
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51734,854,0.57 [0.51-0.65],1.5262665067781167e-17
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45876,3203,0.97 [0.90-1.04],0.3949452556477723
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42854,181,0.92 [0.68-1.24],0.5813604679790283
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,51000,2759,0.91 [0.84-0.98],0.0151415410436747
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45962,3289,0.85 [0.79-0.91],5.007088058659484e-06
PLA2G1B,Phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,51038,255,1.11 [0.87-1.42],0.3907526301422982
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,52072,669,1.07 [0.92-1.25],0.3894912573138572
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",35081,118,0.96 [0.67-1.40],0.8503723464574813
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,48475,163,0.93 [0.68-1.27],0.6423664275422669
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49311,999,0.92 [0.81-1.04],0.1837308775737818
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,51249,464,1.07 [0.88-1.29],0.5085050259847252
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51910,648,0.85 [0.73-1.00],0.0465007787032177
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,51058,101,1.29 [0.87-1.91],0.2095259233271222
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,52038,122,0.84 [0.59-1.20],0.3438170330592619
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50934,149,1.13 [0.81-1.57],0.4699293449695009
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,48910,575,0.99 [0.84-1.18],0.9508821837242118
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,51097,2762,1.01 [0.94-1.10],0.7117923970305748
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51989,1217,0.89 [0.79-0.99],0.0367743993185534
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50865,5182,0.91 [0.86-0.96],0.0012439342402868
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,51302,108,0.63 [0.44-0.91],0.014024291226714
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,51769,507,0.88 [0.74-1.05],0.1631492558158827
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,50907,122,0.87 [0.60-1.25],0.4388997495335308
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,52034,138,0.96 [0.68-1.35],0.7957707191382201
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48462,150,0.92 [0.65-1.29],0.6263672397760165
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48476,164,0.89 [0.65-1.22],0.4678372563810735
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,50747,218,0.67 [0.52-0.87],0.0026308632957102
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,49055,720,1.01 [0.86-1.18],0.9093340985484664
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51929,648,0.97 [0.83-1.15],0.7569999240031797
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,35282,279,0.99 [0.77-1.26],0.9130615461935064
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51738,209,1.16 [0.87-1.55],0.3077562937372077
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50728,2416,1.00 [0.92-1.09],0.9917088345293968
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,49089,7613,0.98 [0.94-1.03],0.5177275570822178
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51363,406,0.78 [0.64-0.95],0.0117948470384112
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",49141,829,1.11 [0.97-1.28],0.1316108625807998
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51917,599,0.78 [0.66-0.91],0.0019765629980336
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41410,1309,0.97 [0.86-1.08],0.540073033219129
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50936,151,0.95 [0.69-1.32],0.7678378695777819
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,51064,279,1.02 [0.80-1.29],0.9012084805842592
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,51104,332,0.82 [0.66-1.01],0.0675390642479714
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48503,191,0.97 [0.72-1.30],0.8449849054760298
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,48450,115,0.81 [0.55-1.17],0.2592436614840345
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,51829,1044,0.97 [0.86-1.10],0.6721861729610742
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,49463,1128,0.99 [0.88-1.11],0.8088640738296247
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,52028,860,0.88 [0.77-1.00],0.0564243102511177
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50896,111,1.29 [0.87-1.91],0.205448524598477
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,52071,156,0.80 [0.59-1.11],0.18188269106601
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,51577,969,0.97 [0.85-1.10],0.5859870258063702
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51417,99,1.20 [0.80-1.81],0.3733364427203469
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,52044,334,0.93 [0.75-1.16],0.5425768785456231
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48414,102,1.15 [0.77-1.72],0.5024267412731488
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,52072,676,1.08 [0.92-1.25],0.3432924428253872
PLA2G1B,Phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50962,248,1.12 [0.87-1.43],0.3774140584133779
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50922,199,0.99 [0.74-1.31],0.9334172410883864
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,51246,792,0.97 [0.84-1.11],0.6276816381953928
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51718,473,0.53 [0.45-0.62],3.74344366410548e-14
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,50052,108,0.73 [0.50-1.06],0.1019969402119851
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50059,115,0.97 [0.66-1.42],0.870423987596414
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51855,106,0.81 [0.56-1.19],0.2853757088859543
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51542,293,1.00 [0.79-1.26],0.9927995792566264
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4227,123,1.35 [1.00-1.83],0.0493907812839575
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5129,206,0.79 [0.64-0.99],0.0373945080128215
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50910,187,0.96 [0.71-1.29],0.7890534051904956
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51632,2087,0.91 [0.84-1.00],0.0393133500706586
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51337,1393,0.90 [0.80-1.00],0.0428870846524671
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50392,448,0.93 [0.76-1.12],0.4251273007221604
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51900,1446,1.04 [0.93-1.15],0.4936323090429679
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,52052,137,0.93 [0.66-1.30],0.6584004304673885
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51752,1298,1.01 [0.90-1.13],0.861398133476859
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51984,735,1.02 [0.88-1.18],0.8339729196569243
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51886,360,0.79 [0.64-0.97],0.0250557409035716
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,50063,119,0.77 [0.54-1.09],0.1437378194551659
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,50079,135,0.88 [0.63-1.24],0.4693479688452986
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,50053,109,0.95 [0.64-1.39],0.7743899331171488
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51883,1424,0.96 [0.87-1.07],0.4739680052351919
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50830,371,0.93 [0.75-1.14],0.460653270245239
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50554,100,0.76 [0.51-1.13],0.1809957592711416
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51451,202,0.88 [0.67-1.17],0.3866157757727934
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51796,547,1.10 [0.93-1.31],0.2638662210734226
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50839,385,1.10 [0.89-1.35],0.3744935955758769
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51748,222,0.80 [0.61-1.04],0.0992427908981621
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51409,950,1.00 [0.88-1.13],0.9560742496222844
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,51005,282,1.12 [0.88-1.42],0.3586347428174813
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48857,4375,0.99 [0.93-1.05],0.7246572967483166
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51725,476,1.08 [0.90-1.30],0.3891670915342812
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,52031,308,0.89 [0.71-1.12],0.3372412894770189
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50769,825,0.87 [0.76-1.00],0.0440773931792444
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51381,132,1.07 [0.75-1.51],0.7132372113092543
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,52026,111,0.99 [0.68-1.44],0.9463057103166952
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,50115,171,1.05 [0.78-1.43],0.7379661405443786
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50242,298,0.92 [0.73-1.16],0.4825436946151209
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49783,238,0.74 [0.57-0.95],0.0189539263905816
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50578,124,1.32 [0.92-1.90],0.1319389562288484
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49671,126,0.82 [0.57-1.17],0.2723293293659249
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50634,175,0.80 [0.59-1.08],0.1393827809953262
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50850,391,1.04 [0.85-1.28],0.6840573910943235
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,50202,258,0.84 [0.66-1.08],0.1779055162860581
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49768,223,0.91 [0.69-1.20],0.5052621452697023
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49716,171,0.97 [0.71-1.32],0.8381030144858638
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,48107,3625,1.00 [0.93-1.07],0.9565605555356416
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,50084,140,0.78 [0.56-1.10],0.1520208142101228
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51550,827,0.96 [0.84-1.11],0.6085014733165398
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50839,116,0.89 [0.62-1.29],0.5408375102952616
PLA2G1B,Phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),51064,341,0.88 [0.71-1.09],0.2316324768562255
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51648,176,1.09 [0.80-1.48],0.5942799194524402
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51982,242,0.98 [0.76-1.27],0.8830649718128651
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51807,259,0.95 [0.74-1.22],0.6899010195390144
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51593,121,0.94 [0.65-1.37],0.7554386659113681
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,51597,125,1.07 [0.74-1.54],0.7196456417755756
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51874,1814,0.96 [0.87-1.05],0.3380048475165537
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51357,1297,0.91 [0.82-1.02],0.1093086706548109
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50314,254,1.06 [0.82-1.36],0.6513679477390902
PLA2G1B,Phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,50233,173,0.94 [0.70-1.28],0.7142802771210519
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,51582,152,1.19 [0.86-1.65],0.2986360966050135
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51861,431,1.08 [0.89-1.32],0.4246653121418603
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51559,129,1.13 [0.79-1.61],0.4952113362429807
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,48000,239,1.20 [0.93-1.56],0.1629454567363105
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47995,234,1.20 [0.92-1.56],0.1726983264833255
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35675,237,0.90 [0.69-1.18],0.4472910582637451
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51805,565,0.99 [0.83-1.18],0.918753763486776
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38457,3561,0.94 [0.88-1.01],0.0748527308988403
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38947,3509,0.94 [0.88-1.01],0.0918845454308664
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),51247,280,0.92 [0.73-1.16],0.4832846649412605
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47925,164,0.88 [0.65-1.19],0.3958270288191085
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,45138,717,0.99 [0.85-1.15],0.885156906649405
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44538,117,1.11 [0.77-1.61],0.5807808070451217
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,50029,5608,0.97 [0.92-1.02],0.2747489840766397
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49301,142,0.89 [0.64-1.26],0.5196348081615664
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,49470,311,0.72 [0.57-0.90],0.004313114159603
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51667,2396,0.97 [0.89-1.05],0.4294388200347768
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49374,215,1.24 [0.93-1.64],0.1391240611944069
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47905,10596,0.99 [0.95-1.03],0.6310295072072505
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49896,737,1.04 [0.89-1.21],0.6271321719247905
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,49905,634,0.89 [0.76-1.04],0.1356815018594319
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,45053,632,1.04 [0.89-1.22],0.6235346397402424
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49458,577,1.06 [0.90-1.25],0.5150267828648505
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51624,3863,1.01 [0.95-1.08],0.7016743729248835
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49529,648,1.05 [0.90-1.23],0.5440761511343398
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,50050,1762,1.01 [0.92-1.11],0.7710255500282366
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,52048,666,1.08 [0.93-1.26],0.32894478832171
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,49374,215,0.89 [0.68-1.18],0.4279970022136963
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51568,1964,1.06 [0.97-1.15],0.2343937617057438
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,51593,4012,0.98 [0.92-1.04],0.5329443383796726
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50844,1685,0.97 [0.88-1.07],0.5113734624483983
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,47684,103,0.76 [0.52-1.13],0.1770900395750457
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51894,807,1.09 [0.95-1.25],0.2392467071876768
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51855,2611,1.00 [0.93-1.08],0.9216537093602688
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,49585,2004,1.01 [0.92-1.10],0.904668546569272
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,47894,313,0.87 [0.70-1.09],0.2317018392047799
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",51113,3352,1.02 [0.95-1.09],0.6469510451057838
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51917,535,1.04 [0.88-1.24],0.6288979466803947
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,47817,236,0.88 [0.68-1.15],0.3552510251221413
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,52023,482,0.98 [0.81-1.19],0.848024847730675
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,51221,134,1.57 [1.13-2.18],0.0068810707057055
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35546,108,0.86 [0.59-1.26],0.4454020687915169
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51524,1920,1.05 [0.96-1.15],0.2895672717265357
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49726,567,0.99 [0.83-1.18],0.8896681733078595
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,48267,506,0.91 [0.76-1.09],0.3054253076195132
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51277,416,0.86 [0.71-1.04],0.1122556864674411
PLA2G1B,Phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23987,229,1.02 [0.77-1.35],0.8823375894626311
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36783,129,0.73 [0.51-1.03],0.0739443632772629
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,51748,292,0.97 [0.76-1.24],0.8074262936879886
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,39170,182,1.28 [0.95-1.73],0.1086811574991008
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,48353,372,0.98 [0.80-1.21],0.8813285343602566
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,51120,185,1.27 [0.95-1.70],0.1077691173904524
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50268,150,0.45 [0.34-0.60],3.9934115664590606e-08
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39870,882,1.01 [0.88-1.16],0.8554055271559775
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",48187,206,1.03 [0.78-1.35],0.8442484479398049
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",51228,206,1.03 [0.78-1.35],0.8439717394148922
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,48394,413,1.04 [0.85-1.26],0.7235565892981461
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,49982,2001,0.95 [0.87-1.04],0.2789022643555028
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,39609,621,0.98 [0.84-1.16],0.8501989910198822
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,48080,99,0.50 [0.35-0.71],0.0001519010727218
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51782,214,0.59 [0.46-0.75],2.7735752170909143e-05
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,48832,250,1.10 [0.84-1.43],0.4770988395152057
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,48694,167,1.09 [0.79-1.49],0.6166622051722825
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51762,378,1.29 [1.05-1.59],0.0148177399866227
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,51551,3383,0.93 [0.87-0.99],0.0342948451801563
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,48715,188,1.33 [0.99-1.79],0.061235027296523
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51361,138,1.33 [0.94-1.87],0.1026301360559909
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48704,177,1.35 [0.99-1.83],0.0573504186121845
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,50568,460,0.92 [0.76-1.11],0.379290421231005
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46728,4492,0.99 [0.93-1.05],0.7532106047194664
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,51821,365,0.90 [0.72-1.12],0.334597830150195
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,51825,1707,0.86 [0.78-0.94],0.0015700828569251
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47696,8708,1.01 [0.96-1.05],0.7239974474281445
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",51227,1119,0.92 [0.81-1.04],0.1750007064617503
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51897,962,0.93 [0.82-1.06],0.3027800318787123
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50336,228,0.68 [0.52-0.88],0.0036539958503869
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,50042,131,0.82 [0.58-1.17],0.2699254184919822
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51440,2858,1.04 [0.96-1.12],0.3594879998711909
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,50072,224,0.89 [0.68-1.18],0.4233562536659982
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50812,2831,0.94 [0.87-1.01],0.0891988649945736
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,43018,6364,0.92 [0.88-0.97],0.0020899766621074
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,39389,401,1.00 [0.82-1.22],0.9985551863338938
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51904,323,0.93 [0.74-1.15],0.4991918352672823
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51890,113,1.02 [0.68-1.51],0.9412396719446114
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50377,259,0.71 [0.56-0.90],0.005423575601514
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36951,297,1.27 [1.01-1.61],0.0450949083278657
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,40089,1101,0.98 [0.86-1.11],0.7428997012777401
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,39713,725,1.10 [0.94-1.27],0.2313338135337149
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,44034,5046,0.98 [0.92-1.04],0.4377591904044694
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,40073,1085,1.03 [0.91-1.16],0.6651193837979161
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40310,16716,0.99 [0.96-1.03],0.7399254618068866
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,50924,2342,1.05 [0.97-1.15],0.221846033682218
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,50216,108,0.68 [0.46-0.98],0.0409327229652404
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38609,2527,0.99 [0.91-1.07],0.7642733175932594
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",50245,127,0.88 [0.62-1.25],0.4802183585588435
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,48782,6546,1.01 [0.96-1.06],0.7168991598610819
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,51904,105,1.07 [0.71-1.62],0.7370584272027108
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,36767,113,1.15 [0.78-1.69],0.4704541272957698
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,44057,1821,1.07 [0.98-1.18],0.1458510174118394
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42444,208,1.08 [0.82-1.43],0.5886639483377121
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36847,193,0.68 [0.51-0.90],0.0081331095931383
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48872,290,1.10 [0.86-1.41],0.4286892634055659
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37761,1107,0.88 [0.77-1.00],0.0444192551990074
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,52012,748,0.74 [0.64-0.85],3.209490308212314e-05
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,50047,1520,1.00 [0.90-1.11],0.9623170849725312
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50548,2021,1.02 [0.93-1.11],0.7414661830015081
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39369,381,0.88 [0.72-1.08],0.2337445604653586
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,40203,1215,0.93 [0.83-1.05],0.2522634046078759
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51970,268,0.93 [0.72-1.19],0.5692899789406164
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42373,137,0.95 [0.67-1.34],0.7735322293081002
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39387,2733,1.00 [0.92-1.08],0.9751952692393704
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48550,569,0.87 [0.74-1.03],0.1131353904137115
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48298,317,0.99 [0.78-1.24],0.901133514980616
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,40168,3514,0.98 [0.92-1.06],0.6631002112105531
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,48026,11372,0.96 [0.92-0.99],0.0230744974147248
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,50021,411,0.89 [0.72-1.08],0.2370169526419024
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,51521,1403,0.85 [0.76-0.94],0.0026821266278235
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40329,1341,0.95 [0.85-1.06],0.3826182544416037
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48287,306,0.82 [0.66-1.03],0.0889919312141239
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51762,827,0.85 [0.74-0.98],0.025240204011769
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40911,1923,0.96 [0.88-1.06],0.4305405437073247
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50955,2373,1.05 [0.97-1.14],0.2355464422227682
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50485,377,0.96 [0.78-1.18],0.6699764763552252
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,40132,3478,0.92 [0.86-0.99],0.0208540584849242
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),43038,4050,1.02 [0.96-1.09],0.4769403501102414
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50320,202,0.89 [0.67-1.18],0.4093186230864248
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50302,1775,1.02 [0.93-1.12],0.6759544385068318
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37349,695,0.95 [0.81-1.10],0.4802787224758867
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51870,133,1.13 [0.78-1.63],0.5290518355659637
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37643,989,0.98 [0.86-1.11],0.7458727254305331
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48879,297,0.84 [0.66-1.06],0.1317800532026351
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,52050,114,0.88 [0.60-1.29],0.5057982505236263
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,50120,237,1.00 [0.76-1.31],0.9913031200064304
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,48641,114,1.18 [0.81-1.73],0.3830643120388552
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39525,537,0.94 [0.79-1.12],0.5161532879075448
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48850,323,0.72 [0.58-0.91],0.0052468202000975
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48794,267,0.69 [0.54-0.89],0.0035187342874559
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,42786,550,1.00 [0.85-1.19],0.9575632755106408
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,37007,353,0.96 [0.77-1.19],0.6897579466493281
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,42763,527,1.00 [0.84-1.19],0.9797882734672264
PLA2G1B,Phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,36814,160,1.07 [0.77-1.49],0.6693049455642839
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51905,596,1.08 [0.92-1.28],0.356485328201917
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51420,148,0.82 [0.59-1.15],0.2553671729930598
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47937,318,1.11 [0.88-1.40],0.3903216830228987
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50778,1414,1.02 [0.92-1.13],0.7184096070821469
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49715,351,1.04 [0.84-1.29],0.7169671274691338
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48439,820,0.96 [0.84-1.10],0.5927820986316195
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51450,561,1.12 [0.94-1.32],0.2024506491491597
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51868,979,1.07 [0.94-1.22],0.2865408828417412
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50988,99,0.82 [0.55-1.23],0.3358232575461551
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48923,6467,1.01 [0.96-1.06],0.6931263571130519
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51154,903,0.86 [0.75-0.98],0.0250967789396928
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50887,636,0.84 [0.71-0.98],0.0297366872573284
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51276,1912,1.05 [0.96-1.15],0.3314035185186544
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",52038,111,0.98 [0.67-1.45],0.9310987070394344
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47732,113,0.86 [0.58-1.26],0.4310171878173295
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50356,105,0.72 [0.49-1.05],0.0893961860412032
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51429,540,1.14 [0.96-1.36],0.140243667228669
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48535,916,1.02 [0.89-1.16],0.8079331787994984
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47749,130,1.22 [0.85-1.74],0.2801627103185078
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51897,167,1.06 [0.78-1.44],0.7121065026778887
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49750,386,0.97 [0.79-1.19],0.7681921270597537
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51661,389,0.78 [0.64-0.96],0.0169793354648404
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,51019,130,1.17 [0.83-1.64],0.3766101680547881
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47754,135,1.03 [0.72-1.47],0.8546693363842367
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50905,3286,1.00 [0.93-1.07],0.9560715725809988
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48612,993,0.99 [0.87-1.13],0.9017964442804066
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47757,138,1.15 [0.81-1.62],0.4402711311287793
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51891,619,0.90 [0.77-1.06],0.2061253631190608
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,51030,141,1.00 [0.72-1.41],0.985120020573106
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51778,506,0.85 [0.71-1.02],0.0816750261449828
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51962,653,1.06 [0.91-1.25],0.4430153446364017
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47869,250,1.12 [0.86-1.46],0.3989146020922973
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,48161,542,0.93 [0.78-1.11],0.4085118588804647
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51940,631,1.06 [0.90-1.25],0.4883072692975277
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",48096,477,0.79 [0.67-0.95],0.0095544007913667
PLA2G1B,Phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,52010,280,1.03 [0.81-1.31],0.8214229636407899
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44674,223,0.68 [0.52-0.89],0.0056424368311813
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47388,11370,1.00 [0.96-1.04],0.8663980475578167
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44533,8515,0.97 [0.93-1.02],0.1980255510534279
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44602,151,0.59 [0.43-0.81],0.0011011696739217
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,45135,308,0.97 [0.77-1.22],0.7925665734511113
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,45190,363,0.91 [0.73-1.13],0.3819017648140369
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51569,187,1.04 [0.77-1.39],0.8196612809942596
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",45027,200,0.70 [0.53-0.92],0.0110391068671817
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38302,2284,0.94 [0.86-1.02],0.1501905969041478
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51794,377,0.99 [0.81-1.22],0.9449915666551288
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45721,894,0.89 [0.78-1.02],0.0910927400529657
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,44006,14635,0.99 [0.96-1.03],0.6572582902979539
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,48075,235,0.88 [0.67-1.14],0.3221320130137212
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44754,303,0.75 [0.60-0.95],0.0152153150425774
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45599,1148,0.80 [0.71-0.90],0.0002581195107948
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,50196,5369,0.95 [0.90-1.00],0.0730132280530333
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44998,547,0.74 [0.62-0.87],0.0004818831688517
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44898,447,0.80 [0.66-0.98],0.0292258682080176
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44727,276,0.76 [0.60-0.98],0.035622448815533
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50776,140,1.30 [0.93-1.84],0.1297793021574984
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39423,3405,0.91 [0.85-0.98],0.0115633665335439
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37240,1222,1.26 [1.12-1.40],5.530071428135432e-05
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51917,1205,1.29 [1.15-1.44],8.309611582330382e-06
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36171,153,0.91 [0.65-1.28],0.5857658898056638
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36682,664,1.10 [0.93-1.29],0.2687659106100902
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,45061,610,0.87 [0.74-1.03],0.1025424977252149
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37302,1284,0.88 [0.79-0.99],0.0346965608297066
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44939,112,0.76 [0.52-1.10],0.1481948073677838
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,46095,1268,0.94 [0.84-1.05],0.2823650599197881
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45436,609,1.00 [0.84-1.18],0.9639717700205662
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37219,1201,0.89 [0.79-1.00],0.0528036532730166
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44613,162,0.72 [0.53-0.99],0.0437536186542818
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44574,123,0.81 [0.56-1.17],0.2598438911570472
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47986,146,0.63 [0.46-0.86],0.0033328869115079
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51289,3449,0.96 [0.90-1.03],0.2910400094147174
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,50096,2256,0.98 [0.90-1.07],0.6544124487328247
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51787,906,1.03 [0.90-1.17],0.707654323502209
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,41035,5017,0.99 [0.93-1.05],0.7216537555135611
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,36144,126,0.64 [0.45-0.93],0.0191078668423497
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44641,190,0.79 [0.59-1.06],0.1218710543760698
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,36118,100,1.04 [0.70-1.56],0.8411481342283306
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36270,252,0.98 [0.75-1.27],0.8603210659887888
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48327,487,1.14 [0.95-1.37],0.1584379583795854
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48609,769,1.04 [0.90-1.21],0.6033943632240817
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,52005,202,0.97 [0.73-1.30],0.8571699617984727
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48472,3645,0.94 [0.88-1.00],0.0627956222434995
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44654,203,0.75 [0.56-1.00],0.0495255398198138
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36295,277,0.88 [0.69-1.14],0.3379388896232048
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46287,1460,0.92 [0.83-1.03],0.1395859617309694
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40347,4329,0.92 [0.86-0.98],0.0091700123714865
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50827,191,1.44 [1.08-1.93],0.0137419529036067
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,52033,141,0.84 [0.60-1.18],0.3198322916638135
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44616,165,0.87 [0.64-1.19],0.3889092008734801
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46967,2516,0.92 [0.85-1.00],0.0486616140493458
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44629,178,0.91 [0.67-1.23],0.5406491839479137
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39289,3271,0.97 [0.90-1.04],0.4064563640856159
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,48064,224,1.27 [0.97-1.66],0.0841018003779908
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44559,108,0.70 [0.47-1.04],0.0749326872418959
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,45147,320,0.84 [0.67-1.05],0.133086136658438
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45565,1114,1.05 [0.93-1.18],0.4427366914661308
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51349,713,1.14 [0.98-1.33],0.0896418995370275
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45982,1155,0.84 [0.75-0.95],0.0050208046884456
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51811,880,1.05 [0.91-1.20],0.5172211122137099
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,52027,108,1.57 [1.07-2.29],0.0211173165533096
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44833,382,0.74 [0.60-0.91],0.0042633273934169
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41199,1520,0.92 [0.83-1.03],0.1363899252331448
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45618,1167,0.89 [0.79-1.00],0.0500927269279869
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44908,457,0.73 [0.60-0.88],0.0008393200604166
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",36126,108,0.66 [0.45-0.97],0.0331832159140705
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,41033,5015,1.00 [0.95-1.06],0.8855355752652473
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37338,1320,0.91 [0.82-1.02],0.1132360982029257
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,51103,467,1.05 [0.87-1.26],0.6289809164688601
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51937,134,0.95 [0.67-1.35],0.7793931456427756
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47703,102,1.09 [0.74-1.59],0.6709463265375211
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,36162,144,0.82 [0.58-1.16],0.2676510103659215
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,45030,203,0.99 [0.74-1.32],0.929687147396145
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36936,918,1.03 [0.90-1.17],0.7117669964280346
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,45068,617,0.86 [0.73-1.02],0.076704049818431
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45341,514,0.99 [0.83-1.19],0.9387452345128844
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,45206,379,1.01 [0.82-1.25],0.905537963121256
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40694,117,0.68 [0.47-0.99],0.0455998505770103
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",52035,116,1.64 [1.14-2.36],0.008037129728358
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45637,1186,0.82 [0.73-0.93],0.0013803190728025
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50821,185,1.55 [1.15-2.09],0.004336807642918
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49638,5187,0.91 [0.86-0.96],0.0007022963433481
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44715,264,0.92 [0.71-1.18],0.497284859086206
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45924,1097,1.00 [0.88-1.12],0.9395800590924052
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,49239,474,0.86 [0.72-1.04],0.1225320973770634
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45242,415,0.85 [0.70-1.04],0.1117349609262487
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47963,3136,0.97 [0.90-1.04],0.4126646832633921
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46885,2058,1.01 [0.93-1.11],0.7688582597777123
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44562,111,0.83 [0.57-1.22],0.3509433911354799
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50907,271,1.15 [0.90-1.48],0.2720978415261804
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44779,328,0.92 [0.73-1.16],0.4703668201853956
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44603,152,0.92 [0.66-1.28],0.6316334096165583
PLA2G1B,Phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),36135,117,0.55 [0.39-0.79],0.001117820735866
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49941,3178,1.35 [1.25-1.45],2.393904574928142e-16
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21027,103,0.91 [0.60-1.38],0.6662601189997261
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27364,113,1.08 [0.73-1.62],0.6935385089847659
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51429,655,0.95 [0.81-1.11],0.5256052348113343
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50943,169,0.98 [0.72-1.34],0.9131715052561468
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49862,3099,2.25 [2.11-2.40],2.042071134072816e-126
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51633,166,3.19 [2.57-3.94],1.9285290826424914e-26
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51570,608,1.40 [1.20-1.65],2.613371844357761e-05
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,45865,472,0.87 [0.72-1.05],0.1406866819552278
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,46927,164,5.89 [5.01-6.94],1.882067255787887e-101
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22700,3343,1.06 [0.99-1.13],0.1070583707748941
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27597,346,1.00 [0.80-1.25],0.9941950976202452
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,21107,183,1.03 [0.76-1.42],0.8323778838981057
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21327,403,0.95 [0.76-1.18],0.6514226883128323
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21943,1019,0.87 [0.76-0.99],0.0322839948770463
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43460,10819,1.08 [1.04-1.13],7.483125048168523e-05
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51637,170,1.36 [1.01-1.83],0.0443240848731795
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19564,207,0.77 [0.58-1.01],0.0549168911113125
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46745,590,1.23 [1.04-1.46],0.0165237324581116
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21985,2628,1.12 [1.03-1.20],0.0055889887360373
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27513,411,0.80 [0.66-0.98],0.0335068670332523
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19594,237,0.94 [0.72-1.21],0.6148674357719595
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27601,131,1.21 [0.83-1.76],0.3332466760185923
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21234,310,0.94 [0.73-1.20],0.6185876508539878
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45552,159,0.92 [0.67-1.27],0.6244751809352729
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23431,2507,0.89 [0.82-0.97],0.0055867465116352
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19468,111,1.78 [1.25-2.54],0.0014011580690724
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21072,148,0.86 [0.61-1.21],0.3902452901124732
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",52045,131,1.24 [0.88-1.76],0.216592654134976
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",52053,133,0.86 [0.61-1.22],0.3971621374437158
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49955,4562,0.98 [0.92-1.04],0.4393635180244714
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46841,1448,1.03 [0.92-1.14],0.6322292829420084
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27371,120,0.84 [0.57-1.22],0.3586924513601005
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51931,969,1.58 [1.39-1.79],5.871756448434641e-13
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19670,313,1.30 [1.03-1.62],0.0247687568635399
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19641,284,0.86 [0.68-1.09],0.2234441701276729
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19589,232,1.16 [0.90-1.50],0.2501602785195276
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51992,144,1.26 [0.90-1.76],0.1824261384653814
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48905,3512,1.01 [0.95-1.08],0.7215497298017128
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27313,211,0.88 [0.66-1.17],0.3734259328084942
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21083,159,0.82 [0.59-1.14],0.23240121694149
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21302,378,0.83 [0.67-1.02],0.0762436245070821
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21039,115,0.96 [0.65-1.42],0.8498899562849247
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21133,209,0.68 [0.51-0.89],0.0055658749328325
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46842,687,1.29 [1.10-1.52],0.0014875483836567
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51284,322,1.69 [1.37-2.10],1.32609112094079e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21241,317,0.94 [0.74-1.19],0.5873928563470128
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21032,108,1.33 [0.88-2.00],0.176423005635291
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21589,665,0.93 [0.79-1.10],0.395080006769602
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21088,164,0.80 [0.59-1.10],0.1782958011488815
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21523,599,0.93 [0.79-1.10],0.4065365192800029
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51565,98,2.39 [1.68-3.41],1.5540761822508006e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19625,268,0.95 [0.75-1.21],0.6792931012654042
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51562,5407,1.49 [1.41-1.58],2.127626303272737e-47
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46394,239,1.32 [1.01-1.74],0.0442254286967369
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,47030,267,1.79 [1.41-2.27],1.8089500648974328e-06
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50887,113,0.81 [0.55-1.18],0.2739084556983752
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45839,446,1.02 [0.85-1.24],0.808353372955628
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51581,807,0.94 [0.81-1.08],0.3732960229722211
PLA2G1B,Phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21071,147,0.84 [0.60-1.18],0.3230599878522063
